Literature DB >> 18185924

Saccadic impairments in Huntington's disease.

A Peltsch1, A Hoffman, I Armstrong, G Pari, D P Munoz.   

Abstract

Huntington's disease (HD), a progressive neurological disorder involving degeneration in basal ganglia structures, leads to abnormal control of saccadic eye movements. We investigated whether saccadic impairments in HD (N = 9) correlated with clinical disease severity to determine the relationship between saccadic control and basal ganglia pathology. HD patients and age/sex-matched controls performed various eye movement tasks that required the execution or suppression of automatic or voluntary saccades. In the "immediate" saccade tasks, subjects were instructed to look either toward (pro-saccade) or away from (anti-saccade) a peripheral stimulus. In the "delayed" saccade tasks (pro-/anti-saccades; delayed memory-guided sequential saccades), subjects were instructed to wait for a central fixation point to disappear before initiating saccades towards or away from a peripheral stimulus that had appeared previously. In all tasks, mean saccadic reaction time was longer and more variable amongst the HD patients. On immediate anti-saccade trials, the occurrence of direction errors (pro-saccades initiated toward stimulus) was higher in the HD patients. In the delayed tasks, timing errors (eye movements made prior to the go signal) were also greater in the HD patients. The increased variability in saccadic reaction times and occurrence of errors (both timing and direction errors) were highly correlated with disease severity, as assessed with the Unified Huntington's Disease Rating Scale, suggesting that saccadic impairments worsen as the disease progresses. Thus, performance on voluntary saccade paradigms provides a sensitive indicator of disease progression in HD.

Entities:  

Mesh:

Year:  2008        PMID: 18185924     DOI: 10.1007/s00221-007-1248-x

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  53 in total

1.  Reversible inactivation of macaque dorsomedial frontal cortex: effects on saccades and fixations.

Authors:  M A Sommer; E J Tehovnik
Journal:  Exp Brain Res       Date:  1999-02       Impact factor: 1.972

Review 2.  Role of the basal ganglia in the control of purposive saccadic eye movements.

Authors:  O Hikosaka; Y Takikawa; R Kawagoe
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

3.  Control of volitional and reflexive saccades in Tourette's syndrome.

Authors:  A L LeVasseur; J R Flanagan; R J Riopelle; D P Munoz
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

4.  Interaction of the frontal eye field and superior colliculus for saccade generation.

Authors:  D P Hanes; R H Wurtz
Journal:  J Neurophysiol       Date:  2001-02       Impact factor: 2.714

Review 5.  Structural and functional evolution of the basal ganglia in vertebrates.

Authors:  A Reiner; L Medina; C L Veenman
Journal:  Brain Res Brain Res Rev       Date:  1998-12

6.  Population coding of saccadic eye movements by neurons in the superior colliculus.

Authors:  C Lee; W H Rohrer; D L Sparks
Journal:  Nature       Date:  1988-03-24       Impact factor: 49.962

7.  Combined eye-head gaze shifts to visual and auditory targets in humans.

Authors:  J E Goldring; M C Dorris; B D Corneil; P A Ballantyne; D P Munoz
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

8.  Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata.

Authors:  O Hikosaka; R H Wurtz
Journal:  J Neurophysiol       Date:  1985-01       Impact factor: 2.714

9.  Saccades in Huntington's disease: predictive tracking and interaction between release of fixation and initiation of saccades.

Authors:  J R Tian; D S Zee; A G Lasker; S E Folstein
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 10.  Huntington's disease: pathogenesis, diagnosis and treatment.

Authors:  S E Purdon; E Mohr; V Ilivitsky; B D Jones
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

View more
  25 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

2.  Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.

Authors:  Saumil S Patel; Joseph Jankovic; Ashley J Hood; Cameron B Jeter; Anne B Sereno
Journal:  J Neurol Sci       Date:  2011-10-21       Impact factor: 3.181

3.  Preclinical assessment of CNS drug action using eye movements in mice.

Authors:  Hugh Cahill; Amir Rattner; Jeremy Nathans
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

4.  Peripheral vision benefits spatial learning by guiding eye movements.

Authors:  Naohide Yamamoto; John W Philbeck
Journal:  Mem Cognit       Date:  2013-01

5.  Novel n-back spatial working memory task using eye movement response.

Authors:  Cameron B Jeter; Saumil S Patel; Anne B Sereno
Journal:  Behav Res Methods       Date:  2011-09

Review 6.  Mechanisms of saccade suppression revealed in the anti-saccade task.

Authors:  Brian C Coe; Douglas P Munoz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

7.  Impact of Huntington's Disease on Mental Rotation Performance in Motor Pre-Symptomatic Individuals.

Authors:  Shahin Nasr; Herminia D Rosas
Journal:  J Huntingtons Dis       Date:  2019

8.  Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; Veronique Bragulat; John West; Jacqueline Jackson; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David Kareken; Tatiana Foroud
Journal:  Neuropsychology       Date:  2011-05       Impact factor: 3.295

Review 9.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

10.  Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.

Authors:  Hannah M Kersten; Helen V Danesh-Meyer; Dean H Kilfoyle; Richard H Roxburgh
Journal:  J Neurol       Date:  2015-08-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.